These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

159 related items for PubMed ID: 2447421

  • 1. Cyclic GMP in nicorandil-induced vasodilatation and tolerance development.
    Kukovetz WR, Holzmann S.
    J Cardiovasc Pharmacol; 1987; 10 Suppl 8():S25-30. PubMed ID: 2447421
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Molecular mechanism of action of nicorandil.
    Kukovetz WR, Holzmann S, Pöch G.
    J Cardiovasc Pharmacol; 1992; 20 Suppl 3():S1-7. PubMed ID: 1282168
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Mechanism of vasodilation by nitrates: role of cyclic GMP.
    Kukovetz WR, Holzmann S, Romanin C.
    Cardiology; 1987; 74 Suppl 1():12-9. PubMed ID: 2886220
    [Abstract] [Full Text] [Related]

  • 6. Cyclic GMP as possible mediator of coronary arterial relaxation by nicorandil (SG-75).
    Holzmann S.
    J Cardiovasc Pharmacol; 1983; 5(3):364-70. PubMed ID: 6191133
    [Abstract] [Full Text] [Related]

  • 7. Mechanisms of nitrate-induced vasodilatation and tolerance.
    Kukovetz WR, Holzmann S.
    Eur J Clin Pharmacol; 1990; 38 Suppl 1():S9-14. PubMed ID: 1972361
    [Abstract] [Full Text] [Related]

  • 8. Dual mechanism of the relaxing effect of nicorandil by stimulation of cyclic GMP formation and by hyperpolarization.
    Kukovetz WR, Holzmann S, Braida C, Pöch G.
    J Cardiovasc Pharmacol; 1991 Apr; 17(4):627-33. PubMed ID: 1711631
    [Abstract] [Full Text] [Related]

  • 9. Nitrate tolerance induced by nicorandil or nitroglycerin is associated with minimal loss of nicorandil vasodilator activity.
    Henry PJ, Horowitz JD, Louis WJ.
    J Cardiovasc Pharmacol; 1990 Mar; 15(3):365-70. PubMed ID: 1691358
    [Abstract] [Full Text] [Related]

  • 10. Nicorandil-induced vasorelaxation: functional evidence for K+ channel-dependent and cyclic GMP-dependent components in a single vascular preparation.
    Meisheri KD, Cipkus-Dubray LA, Hosner JM, Khan SA.
    J Cardiovasc Pharmacol; 1991 Jun; 17(6):903-12. PubMed ID: 1714013
    [Abstract] [Full Text] [Related]

  • 11. Contribution of cyclic GMP formation to KRN2391-induced relaxation in coronary artery of the pig.
    Jinno Y, Kasai H, Ohta H, Nishikori K, Fukushima H, Ogawa N.
    Br J Pharmacol; 1992 Aug; 106(4):906-9. PubMed ID: 1327392
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Antiplatelet effects of a novel antianginal agent, nicorandil.
    Jaraki O, Strauss WE, Francis S, Loscalzo J, Stamler JS.
    J Cardiovasc Pharmacol; 1994 Jan; 23(1):24-30. PubMed ID: 7511731
    [Abstract] [Full Text] [Related]

  • 20. Relationship between relaxation and cyclic GMP formation caused by nicorandil in canine mesenteric artery.
    Endoh M, Taira N.
    Naunyn Schmiedebergs Arch Pharmacol; 1983 May; 322(4):319-21. PubMed ID: 6306488
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.